Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study).

Autor: Christian Daugaard Peters, Krista Dybtved Kjaergaard, Jens Dam Jensen, Kent Lodberg Christensen, Charlotte Strandhave, Ida Noerager Tietze, Marija Kristina Novosel, Bo Martin Bibby, Bente Jespersen
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Zdroj: PLoS ONE, Vol 10, Iss 6, p e0126882 (2015)
Druh dokumentu: article
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0126882
Popis: Little is known about the tolerability of antihypertensive drugs during hemodialysis treatment. The present study evaluated the use of the angiotensin II receptor blocker (ARB) irbesartan.Randomized, double-blind, placebo-controlled, one-year intervention trial.Eighty-two hemodialysis patients with urine output >300 mL/day and dialysis vintage
Databáze: Directory of Open Access Journals
Pro tento záznam nejsou dostupné žádné jednotky.